Catalogue profile
This catalogue item groups CJC-1295 without DAC and Ipamorelin as two separately named peptide references. The displayed product configuration is 5 mg plus 5 mg.
Documentation
Compare the product name, presentation on the label and batch number before internal registration. This description is intended for product identification, not as information on use or effects.
Scientific mechanism
This blend combines two different ligand classes: CJC-1295 no DAC as a GHRH analogue and Ipamorelin as a synthetic pentapeptide associated with the GHSR or ghrelin receptor in receptor studies. The two molecular profiles can be investigated separately; no synergistic activity is attributed to the combination.
Batch documentation
Before each study, always check the product label, selected presentation and batch number. Compare these details, where available, with the batch documentation and lab results.
Important research-use notice
This item is intended exclusively for controlled analytical and in-vitro laboratory research. It is not intended for human or animal consumption, use, administration, diagnosis, prevention or treatment. VLT Labs does not provide dosage, medical, health or application advice.
